A small proportion of individuals affected by FXS with different levels of severity show deletion or point mutation in the Fmr1 gene, that in turn cause the complete loss of FMRP or the production of a functionally deficient protein (5–7). The gene discussed is FMR1; the disease is fragile X syndrome.